Brenda Moura

7.1k total citations
40 papers, 364 citations indexed

About

Brenda Moura is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Brenda Moura has authored 40 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Cardiology and Cardiovascular Medicine, 8 papers in Pulmonary and Respiratory Medicine and 7 papers in Surgery. Recurrent topics in Brenda Moura's work include Heart Failure Treatment and Management (20 papers), Cardiovascular Function and Risk Factors (13 papers) and Cardiac pacing and defibrillation studies (9 papers). Brenda Moura is often cited by papers focused on Heart Failure Treatment and Management (20 papers), Cardiovascular Function and Risk Factors (13 papers) and Cardiac pacing and defibrillation studies (9 papers). Brenda Moura collaborates with scholars based in Portugal, Italy and France. Brenda Moura's co-authors include José Silva‐Cardoso, Henrique Lecour, Francisco Rocha‐Gonçalves, Luís Martins, Elisabete Martins, Maria Júlia Maciel, Paulo Bettencourt, Patrizio Lancellotti, Johann Bauersachs and Héctor Bueno and has published in prestigious journals such as SHILAP Revista de lepidopterología, CHEST Journal and European Heart Journal.

In The Last Decade

Brenda Moura

36 papers receiving 351 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brenda Moura Portugal 11 265 69 62 43 43 40 364
Marco Metra Italy 10 222 0.8× 36 0.5× 66 1.1× 24 0.6× 40 0.9× 41 328
Siu‐Hin Wan United States 9 400 1.5× 19 0.3× 42 0.7× 61 1.4× 62 1.4× 35 487
Wasiq Faraz Rawasia United States 7 152 0.6× 29 0.4× 81 1.3× 64 1.5× 92 2.1× 18 305
Rolf Handschin Switzerland 6 322 1.2× 20 0.3× 46 0.7× 37 0.9× 45 1.0× 7 396
Edwin Straumann Switzerland 11 225 0.8× 50 0.7× 81 1.3× 30 0.7× 45 1.0× 22 347
Naveen Seecheran Trinidad and Tobago 12 496 1.9× 24 0.3× 252 4.1× 26 0.6× 87 2.0× 57 626
Nazmiye Çakmak Türkiye 11 249 0.9× 16 0.2× 95 1.5× 59 1.4× 81 1.9× 33 400
Stylianos Daios Greece 11 173 0.7× 17 0.2× 62 1.0× 64 1.5× 114 2.7× 55 360
Ashish Correa United States 11 123 0.5× 32 0.5× 76 1.2× 22 0.5× 35 0.8× 31 289
Hakkı Kaya Türkiye 10 129 0.5× 14 0.2× 41 0.7× 50 1.2× 26 0.6× 47 272

Countries citing papers authored by Brenda Moura

Since Specialization
Citations

This map shows the geographic impact of Brenda Moura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brenda Moura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brenda Moura more than expected).

Fields of papers citing papers by Brenda Moura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brenda Moura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brenda Moura. The network helps show where Brenda Moura may publish in the future.

Co-authorship network of co-authors of Brenda Moura

This figure shows the co-authorship network connecting the top 25 collaborators of Brenda Moura. A scholar is included among the top collaborators of Brenda Moura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brenda Moura. Brenda Moura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hulot, Jean‐Sébastien, Jozine M. ter Maaten, Antoni Bayés‐Genís, et al.. (2025). Heart Failure Improvement, Remission, and Recovery: A European Journal of Heart Failure Expert Consensus Document. European Journal of Heart Failure. 27(10). 1807–1819. 1 indexed citations
2.
3.
Bayés‐Genís, Antoni, Mark C. Petrie, Brenda Moura, et al.. (2024). Awareness, Access, and Adoption of Natriuretic Peptides for Diagnosis of Heart Failure. ESC Heart Failure. 12(1). 54–59. 1 indexed citations
4.
Silva‐Cardoso, José, Inês Araújo, Aurora Andrade, et al.. (2023). conTemporary reflectiOns regarding heart failure manaGEmenT – How to ovERcome the PorTuguese barriers (TOGETHER-PT). Revista Portuguesa de Cardiologia. 43(5). 225–235.
5.
Musella, Francesca, Giuseppe Rosano, Camilla Hage, et al.. (2023). Patient Profiles in Heart Failure with Reduced Ejection Fraction: Prevalence, Characteristics, Treatments and Outcomes in a Real-World Heart Failure Population. European Journal of Heart Failure. 25(8). 1246–1253. 10 indexed citations
6.
Caldeira, Daniel, Dulce Brito, Carlos Aguíar, et al.. (2023). Expert perspectives on strategic factors for the management and prevention of heart failure in Portugal. Revista Portuguesa de Cardiologia. 42(11). 885–891.
7.
8.
Silva‐Cardoso, José, Aurora Andrade, Dulce Brito, et al.. (2021). SGLT-2 inhibitors: A step forward in the treatment of heart failure with reduced ejection fraction. SHILAP Revista de lepidopterología. 40(9). 687–693. 4 indexed citations
9.
Bueno, Héctor, Brenda Moura, Patrizio Lancellotti, & Johann Bauersachs. (2020). The year in cardiovascular medicine 2020: heart failure and cardiomyopathies. European Heart Journal. 42(6). 657–670. 29 indexed citations
10.
Brito, Dulce, Paulo Bettencourt, Davide Carvalho, et al.. (2020). Sodium-Glucose Co-transporter 2 Inhibitors in the Failing Heart: a Growing Potential. Cardiovascular Drugs and Therapy. 34(3). 419–436. 19 indexed citations
11.
Canedo, Paulo, Brenda Moura, Adriana Belo, et al.. (2019). Genetic Variants Are Not Rare in ICD Candidates with Dilated Cardiomyopathy: Time for Next-Generation Sequencing?. Cardiology Research and Practice. 2019. 1–9. 2 indexed citations
12.
Mele, Donato, et al.. (2019). From left ventricular ejection fraction to cardiac hemodynamics: role of echocardiography in evaluating patients with heart failure. Heart Failure Reviews. 25(2). 217–230. 34 indexed citations
13.
Moura, Brenda, Elisabete Martins, Maria Faria, et al.. (2017). The role of biomarkers in dilated cardiomyopathy: Assessment of clinical severity and reverse remodeling. Revista Portuguesa de Cardiologia. 36(10). 709–716. 11 indexed citations
14.
Moura, Brenda, Elisabete Martins, Maria Faria, et al.. (2017). The role of biomarkers in dilated cardiomyopathy: Assessment of clinical severity and reverse remodeling. SHILAP Revista de lepidopterología. 36(10). 709–716.
15.
Martins, Elisabete, et al.. (2016). Prevalence, predictors and prognosis of ventricular reverse remodeling in idiopathic dilated cardiomyopathy. Revista Portuguesa de Cardiologia. 35(5). 253–260. 18 indexed citations
16.
Moura, Brenda. (2012). Anemia and prognosis in acute coronary syndromes. SHILAP Revista de lepidopterología. 31(2). 133–134. 4 indexed citations
17.
Sevila, Raquel García, et al.. (2012). Congenital Complete Atrioventricular Block and Dilated Cardiomyopathy: New Light for an Old Disease. SHILAP Revista de lepidopterología. 2012. 1–2. 1 indexed citations
18.
Silva‐Cardoso, José, et al.. (1999). Pericardial Involvement in Human Immunodeficiency Virus Infection. CHEST Journal. 115(2). 418–422. 37 indexed citations
19.
Silva‐Cardoso, José, Brenda Moura, António Ferreira, et al.. (1998). Predictors of myocardial dysfunction in human immunodeficiency virus-infected patients. Journal of Cardiac Failure. 4(1). 19–26. 7 indexed citations
20.
Moura, Brenda, et al.. (1997). Zidovudine Therapy and Left Ventricular Function and Mass in Human Immunodeficiency Virus-Infected Patients. Cardiology. 88(1). 26–28. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marco Metra Breakdown of academic impact, for papers by Siu‐Hin Wan Breakdown of academic impact, for papers by Wasiq Faraz Rawasia Breakdown of academic impact, for papers by Rolf Handschin Breakdown of academic impact, for papers by Edwin Straumann Breakdown of academic impact, for papers by Naveen Seecheran Breakdown of academic impact, for papers by Nazmiye Çakmak Breakdown of academic impact, for papers by Stylianos Daios Breakdown of academic impact, for papers by Ashish Correa Breakdown of academic impact, for papers by Hakkı Kaya
Rankless by CCL
2026